Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-24-22 | Jun-25-22 | Mar-26-22 | Dec-25-21 | Sep-25-21 | Jun-26-21 | Mar-27-21 | Dec-26-20 |
| | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Revenues: |
| Breast Health | 275.1 | 282.8 | 310.4 | 359.3 | 334.3 | 349.0 | 336.3 | 332.7 |
| Diagnostics | 520.9 | 560.1 | 987.1 | 950.4 | 836.8 | 665.5 | 1,064.5 | 1,128.2 |
| GYN Surgical | 133.3 | 138.1 | 117.3 | 134.3 | 121.9 | 127.9 | 114.2 | 124.0 |
| Skeletal Health | 23.9 | 21.7 | 20.9 | 27.1 | 23.6 | 25.9 | 22.6 | 24.9 |
| Total revenues [+] | 953.2 | 1,002.7 | 1,435.7 | 1,471.1 | 1,316.6 | 1,168.3 | 1,537.6 | 1,609.8 |
| Products | | 837.1 | 1,268.2 | 1,303.3 | | 995.2 | 1,378.8 | 1,455.4 |
| Services | | 165.6 | 167.5 | 167.8 | | 173.1 | 158.8 | 154.4 |
| Revenue growth [+] | -27.6% | -14.2% | -6.6% | -8.6% | -2.2% | 42.0% | 103.4% | 89.3% |
| Breast Health | -17.7% | -19.0% | -7.7% | 8.0% | 15.6% | 55.8% | 9.3% | 0.5% |
| Diagnostics | -37.8% | -15.8% | -7.3% | -15.8% | -10.9% | 25.0% | 233.5% | 262.2% |
| GYN Surgical | 9.4% | 8.0% | 2.7% | 8.3% | 21.7% | 148.3% | 8.3% | 4.1% |
| Skeletal Health | 1.3% | -16.2% | -7.5% | 8.8% | 26.2% | 70.4% | -4.6% | 6.0% |
| Cost of goods sold [+] | 611.3 | 266.3 | 322.6 | 318.1 | -612.4 | 303.9 | 300.7 | 284.5 |
| Cost of services | | 101.5 | 94.2 | 91.8 | | 94.7 | 86.6 | 83.3 |
| Gross profit | 341.9 | 736.4 | 1,113.1 | 1,153.0 | 1,929.0 | 864.4 | 1,236.9 | 1,325.3 |
| Gross margin | 35.9% | 73.4% | 77.5% | 78.4% | 146.5% | 74.0% | 80.4% | 82.3% |
| Selling, general and administrative [+] | 256.5 | 244.2 | 271.9 | 265.3 | 294.5 | 260.0 | 220.4 | 219.5 |
| Sales and marketing | 159.3 | 152.3 | 171.4 | 147.4 | 159.0 | 142.7 | 131.5 | 128.0 |
| General and administrative | 97.2 | 91.9 | 100.5 | 117.9 | 135.5 | 117.3 | 88.9 | 91.5 |
| Research and development | 76.0 | 65.1 | 69.5 | 72.8 | 76.5 | 69.0 | 71.5 | 59.3 |
| Other operating expenses | -160.8 | 197.8 | 177.8 | 177.5 | 1,112.4 | 173.2 | 161.3 | 155.0 |
| EBITDA [+] | 276.8 | 350.1 | 700.0 | 745.4 | 563.4 | 463.3 | 878.9 | 984.3 |
| EBITDA growth | -50.9% | -24.4% | -20.4% | -24.3% | -23.6% | 62.2% | 248.1% | 336.7% |
| EBITDA margin | 29.0% | 34.9% | 48.8% | 50.7% | 42.8% | 39.7% | 57.2% | 61.1% |
| Depreciation | 22.0 | 109.6 | 22.6 | 22.3 | 23.8 | 22.7 | 20.4 | 21.1 |
| EBITA | 254.8 | 240.5 | 677.4 | 723.1 | 539.6 | 440.6 | 858.5 | 963.2 |
| EBITA margin | 26.7% | 24.0% | 47.2% | 49.2% | 41.0% | 37.7% | 55.8% | 59.8% |
| Amortization of intangibles | 84.6 | 11.2 | 83.5 | 85.7 | 94.0 | 78.4 | 74.8 | 71.7 |
| EBIT [+] | 170.2 | 229.3 | 593.9 | 637.4 | 445.6 | 362.2 | 783.7 | 891.5 |
| EBIT growth | -61.8% | -36.7% | -24.2% | -28.5% | -30.7% | 88.6% | 393.5% | 580.5% |
| EBIT margin | 17.9% | 22.9% | 41.4% | 43.3% | 33.8% | 31.0% | 51.0% | 55.4% |
| Non-recurring items | 29.3 | -34.6 | -0.2 | -3.9 | 6.1 | 3.6 | -13.1 | 6.0 |
| Interest expense, net [+] | 14.8 | 20.3 | 21.8 | 25.2 | 22.4 | 21.2 | 21.0 | 27.7 |
| Interest expense | 24.1 | 22.7 | 22.6 | 25.7 | 22.7 | 21.6 | 21.3 | 28.1 |
| Interest income | 9.3 | 2.4 | 0.8 | 0.5 | 0.3 | 0.4 | 0.3 | 0.4 |
| Other income (expense), net [+] | 17.3 | 4.8 | 2.1 | 5.8 | -6.5 | 0.1 | 4.7 | -25.4 |
| Gain (loss) on debt retirement | | | | -0.7 | | | | -21.6 |
| Other | 17.3 | 4.8 | 2.1 | 6.5 | -6.5 | 0.1 | 4.7 | -3.8 |
| Pre-tax income | 143.4 | 248.4 | 574.4 | 621.9 | 410.6 | 337.5 | 780.5 | 832.4 |
| Income taxes | 24.7 | 20.0 | 118.7 | 122.7 | 81.8 | 69.4 | 161.1 | 179.0 |
| Tax rate | 17.2% | 8.1% | 20.7% | 19.7% | 19.9% | 20.6% | 20.6% | 21.5% |
| Net income | 118.7 | 228.4 | 455.7 | 499.2 | 328.8 | 268.1 | 619.4 | 653.4 |
| Net margin | 12.5% | 22.8% | 31.7% | 33.9% | 25.0% | 22.9% | 40.3% | 40.6% |
| |
| Basic EPS [+] | $0.47 | $0.91 | $1.81 | $1.97 | $1.28 | $1.05 | $2.40 | $2.53 |
| Growth | -63.1% | -12.9% | -24.4% | -22.1% | -31.9% | 99.3% | 565.4% | 75.4% |
| Diluted EPS [+] | $0.47 | $0.90 | $1.80 | $1.95 | $1.27 | $1.04 | $2.38 | $2.50 |
| Growth | -63.1% | -13.0% | -24.4% | -21.9% | -32.1% | 98.4% | 562.8% | 74.5% |
| |
| |
| Shares outstanding (basic) [+] | 251.5 | 250.8 | 251.6 | 253.5 | 257.0 | 256.2 | 258.5 | 258.6 |
| Growth | -2.1% | -2.1% | -2.7% | -2.0% | -2.2% | -1.4% | -1.8% | -3.5% |
| Shares outstanding (diluted) [+] | 253.8 | 253.1 | 253.7 | 256.1 | 259.7 | 258.6 | 260.7 | 261.8 |
| Growth | -2.3% | -2.1% | -2.7% | -2.2% | -1.9% | -0.9% | -1.4% | -2.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|